Clinical Trial Update: A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of XB371 in participants with locally advanced or metastatic solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• XB371

Snippet

Sponsor: Exelixis | Conditions: Solid Tumors | Phase 1 | Status: RECRUITING